Manager firm
Polar Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
⌘K
Manager firm
Polar Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
Share price
383.00p
NAV / share
396.46p2026-05-06
Premium / discount
-3.40%
Fund size
—
OCF
—
Performance fee
—
Gearing
—
Dividend yield
—
| USA | 49.0% | |
| Denmark | 13.0% | |
| Netherlands | 7.0% | |
| UK | 7.0% | |
| Switzerland | 6.0% | |
| Ireland | 4.0% | |
| Belgium | 4.0% | |
| India | 4.0% | |
| Germany | 2.0% | |
| Australia | 2.0% |
| Portfolio yield | 0.40% |
| Unlisted holdings | — |
| Cash & equivalents | 1.00% |
| Total assets | £431.2m |
| Revenue reserves | £0 |
| Net gearing | 0.00% |
| Gross gearing | 0.00% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 121,270,000 |
| Shares issued | 0 |
| Shares purchased | 0 |
| Treasury shares | 0 |
Manager firm
Polar Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
Share price
383.00p
NAV / share
396.46p2026-05-06
Premium / discount
-3.40%
Fund size
—
OCF
—
Performance fee
—
Gearing
—
Dividend yield
—
| USA | 49.0% | |
| Denmark | 13.0% | |
| Netherlands | 7.0% | |
| UK | 7.0% | |
| Switzerland | 6.0% | |
| Ireland | 4.0% | |
| Belgium | 4.0% | |
| India | 4.0% | |
| Germany | 2.0% | |
| Australia | 2.0% |
| Portfolio yield | 0.40% |
| Unlisted holdings | — |
| Cash & equivalents | 1.00% |
| Total assets | £431.2m |
| Revenue reserves | £0 |
| Net gearing | 0.00% |
| Gross gearing | 0.00% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 121,270,000 |
| Shares issued | 0 |
| Shares purchased | 0 |
| Treasury shares | 0 |